Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
International Journal of Laboratory Hematology|August 29, 2018
GlycA is not a useful biomarker of inflammation in sickle cell diseaseJulie K Weisman, Daveena Meeks, Laurel Mendelsohn, et al.
Blood|October 1, 2016
Reversible binding of hemoglobin to band 3 constitutes the molecular switch that mediates O2 regulation of erythrocyte propertiesHaiyan Chu, Mary M McKenna, Nathan A Krump, et al.
British Journal of Haematology|April 23, 2010
NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in AfricaZakari Y Aliyu, Aisha Suleiman, Ester Attah, et al.
Blood Advances|October 19, 2018
The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinaseSebastian Vogel, Taruna Arora, Xunde Wang, et al.
American Journal of Hematology|March 4, 2014
Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell diseaseEduard J van Beers, Leigh Samsel, Laurel Mendelsohn, et al.
Blood|June 12, 2014
Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Krüppel-like factorXunde Wang, Laurel Mendelsohn, Heather Rogers, et al.
Haematologica|April 10, 2010
Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell diseaseAshaunta Tumblin, Anitaben Tailor, Gerard T Hoehn, et al.
Blood|March 26, 2010
High levels of placenta growth factor in sickle cell disease promote pulmonary hypertensionNambirajan Sundaram, Anitaben Tailor, Laurel Mendelsohn, et al.
Circulation Research|November 8, 2014
Iron, inflammation, and early death in adults with sickle cell diseaseEduard J van Beers, Yanqin Yang, Nalini Raghavachari, et al.
American Journal of Hematology|February 29, 2008
Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in NigeriaZakari Y Aliyu, Victor Gordeuk, Vandana Sachdev, et al.
Pageof 3